Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 3
1986 8
1987 9
1988 8
1989 10
1990 9
1991 7
1992 10
1993 12
1994 6
1995 8
1996 8
1997 8
1998 3
1999 6
2000 4
2001 5
2003 5
2004 8
2005 8
2006 3
2007 11
2008 3
2009 6
2010 4
2011 9
2012 8
2013 8
2014 11
2015 13
2016 20
2017 26
2018 25
2019 27
2020 21
2021 30
2022 40
2023 35
2024 20

Text availability

Article attribute

Article type

Publication date

Search Results

426 results

Results by year

Filters applied: . Clear all
Page 1
Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort.
Tam CS, Allan JN, Siddiqi T, Kipps TJ, Jacobs R, Opat S, Barr PM, Tedeschi A, Trentin L, Bannerji R, Jackson S, Kuss BJ, Moreno C, Szafer-Glusman E, Russell K, Zhou C, Ninomoto J, Dean JP, Wierda WG, Ghia P. Tam CS, et al. Among authors: trentin l. Blood. 2022 Jun 2;139(22):3278-3289. doi: 10.1182/blood.2021014488. Blood. 2022. PMID: 35196370 Free PMC article.
Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact.
Baliakas P, Jeromin S, Iskas M, Puiggros A, Plevova K, Nguyen-Khac F, Davis Z, Rigolin GM, Visentin A, Xochelli A, Delgado J, Baran-Marszak F, Stalika E, Abrisqueta P, Durechova K, Papaioannou G, Eclache V, Dimou M, Iliakis T, Collado R, Doubek M, Calasanz MJ, Ruiz-Xiville N, Moreno C, Jarosova M, Leeksma AC, Panayiotidis P, Podgornik H, Cymbalista F, Anagnostopoulos A, Trentin L, Stavroyianni N, Davi F, Ghia P, Kater AP, Cuneo A, Pospisilova S, Espinet B, Athanasiadou A, Oscier D, Haferlach C, Stamatopoulos K; ERIC, the European Research Initiative on CLL. Baliakas P, et al. Among authors: trentin l. Blood. 2019 Mar 14;133(11):1205-1216. doi: 10.1182/blood-2018-09-873083. Epub 2019 Jan 2. Blood. 2019. PMID: 30602617 Free PMC article.
Outcomes in Patients with High-Risk Features after Fixed-Duration Ibrutinib plus Venetoclax: Phase II CAPTIVATE Study in First-Line Chronic Lymphocytic Leukemia.
Allan JN, Flinn IW, Siddiqi T, Ghia P, Tam CS, Kipps TJ, Barr PM, Elinder Camburn A, Tedeschi A, Badoux XC, Jacobs R, Kuss BJ, Trentin L, Zhou C, Szoke A, Abbazio C, Wierda WG. Allan JN, et al. Among authors: trentin l. Clin Cancer Res. 2023 Jul 14;29(14):2593-2601. doi: 10.1158/1078-0432.CCR-22-2779. Clin Cancer Res. 2023. PMID: 37282671 Free PMC article.
Light-chain cardiac amyloidosis for the non-expert: pearls and pitfalls.
De Michieli L, Sinigiani G, De Gaspari M, Branca A, Rizzo S, Basso C, Trentin L, Iliceto S, Perazzolo Marra M, Cipriani A, Berno T. De Michieli L, et al. Among authors: trentin l. Intern Emerg Med. 2023 Oct;18(7):1879-1886. doi: 10.1007/s11739-023-03335-3. Epub 2023 Jun 20. Intern Emerg Med. 2023. PMID: 37338717 Free PMC article. Review.
Rituximab-responsive CIDP.
Briani C, Zara G, Zambello R, Trentin L, Rana M, Zaja F. Briani C, et al. Among authors: trentin l. Eur J Neurol. 2004 Nov;11(11):788. doi: 10.1111/j.1468-1331.2004.00911.x. Eur J Neurol. 2004. PMID: 15525302 No abstract available.
New responsibilities for aged kinases in B-lymphomas.
Piazza F, Manni S, Arjomand A, Visentin A, Trentin L, Semenzato G. Piazza F, et al. Among authors: trentin l. Hematol Oncol. 2020 Feb;38(1):3-11. doi: 10.1002/hon.2694. Epub 2019 Dec 1. Hematol Oncol. 2020. PMID: 31782972 Review.
From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance.
Visentin A, Pravato S, Castellani F, Campagnolo M, Angotzi F, Cavarretta CA, Cellini A, Ruocco V, Salvalaggio A, Tedeschi A, Trentin L, Briani C. Visentin A, et al. Among authors: trentin l. Cancers (Basel). 2022 Mar 18;14(6):1562. doi: 10.3390/cancers14061562. Cancers (Basel). 2022. PMID: 35326711 Free PMC article. Review.
Nanoscale Wetting of Crystalline Cellulose.
Trentin LN, Pereira CS, Silveira RL, Hill S, Sorieul M, Skaf MS. Trentin LN, et al. Biomacromolecules. 2021 Oct 11;22(10):4251-4261. doi: 10.1021/acs.biomac.1c00801. Epub 2021 Sep 13. Biomacromolecules. 2021. PMID: 34515474
Hyper-IgE syndrome.
Presotto F, Trentin L, Agostini C. Presotto F, et al. Among authors: trentin l. N Engl J Med. 1999 Jul 29;341(5):375-6; author reply 376-7. doi: 10.1056/NEJM199907293410517. N Engl J Med. 1999. PMID: 10428668 No abstract available.
BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib.
Bonfiglio S, Sutton LA, Ljungström V, Capasso A, Pandzic T, Weström S, Foroughi-Asl H, Skaftason A, Gellerbring A, Lyander A, Gandini F, Gaidano G, Trentin L, Bonello L, Reda G, Bödör C, Stavroyianni N, Tam CS, Marasca R, Forconi F, Panayiotidis P, Ringshausen I, Jaksic O, Frustaci AM, Iyengar S, Coscia M, Mulligan SP, Ysebaert L, Strugov V, Pavlovsky C, Walewska R, Österborg A, Cortese D, Ranghetti P, Baliakas P, Stamatopoulos K, Scarfò L, Rosenquist R, Ghia P. Bonfiglio S, et al. Among authors: trentin l. Blood Adv. 2023 Jun 27;7(12):2794-2806. doi: 10.1182/bloodadvances.2022008821. Blood Adv. 2023. PMID: 36696464 Free PMC article.
426 results